Horizon Therapeutics PLC (HZNP) Social Stream
HORIZON THERAPEUTICS PUBLIC LTD CO (HZNP) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering HORIZON THERAPEUTICS PUBLIC LTD CO.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 9 | $155 | $107 | $134.1 | $78.76 | 70.26% |
| 2021-12-08 | 10 | $155 | $107 | $134.363 | $78.76 | 70.6% |
| 2022-01-06 | 10 | $156 | $107 | $135.272 | $78.76 | 71.75% |
| 2022-01-18 | 10 | $155 | $107 | $135.09 | $78.76 | 71.52% |
| 2022-03-01 | 10 | $155 | $107 | $134.181 | $78.76 | 70.37% |
| 2022-03-02 | 10 | $155 | $107 | $134.636 | $78.76 | 70.94% |
| 2022-05-02 | 11 | $155 | $121 | $137.727 | $78.76 | 74.87% |
| 2022-05-03 | 11 | $155 | $121 | $137.636 | $78.76 | 74.75% |
| 2022-05-05 | 11 | $155 | $121 | $137 | $78.76 | 73.95% |
| 2022-06-06 | 12 | $155 | $95 | $133.5 | $78.76 | 69.5% |
| 2022-06-14 | 13 | $155 | $95 | $133.923 | $78.76 | 70.04% |
| 2022-07-14 | 12 | $155 | $95 | $133.692 | $78.76 | 69.75% |
| 2022-08-03 | 12 | $155 | $95 | $132.923 | $78.76 | 68.77% |
| 2022-08-04 | 14 | $144 | $71 | $107.846 | $78.76 | 36.93% |
| 2022-09-06 | 13 | $144 | $71 | $107.846 | $78.76 | 36.93% |
| 2022-10-14 | 13 | $144 | $71 | $107.769 | $78.76 | 36.83% |
| 2022-10-19 | 13 | $144 | $71 | $107.692 | $78.76 | 36.73% |
| 2022-10-25 | 13 | $144 | $71 | $107.538 | $78.76 | 36.54% |
| 2022-11-01 | 14 | $144 | $71 | $105.142 | $78.76 | 33.5% |
| 2022-11-02 | 14 | $144 | $71 | $105.214 | $78.76 | 33.59% |
| 2022-11-03 | 14 | $144 | $71 | $106.357 | $78.76 | 35.04% |
The Trend in the Analyst Price Target
Over the past 29 months, HZNP's average price target has gone up $53.03.
HZNP reports an average of 53.89% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-13 | 11 | 155 | 121 | 137.727 | 115.15 | 19.61% |
| 2022-09-06 | 13 | 144 | 71 | 107.846 | 59.63 | 80.86% |
| 2022-10-11 | 13 | 144 | 71 | 107.769 | 63.62 | 69.39% |
| 2022-10-14 | 13 | 144 | 71 | 107.692 | 62.51 | 72.28% |
| 2022-10-25 | 13 | 144 | 71 | 107.538 | 66.13 | 62.62% |
HZNP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.32 | 11 | 1 | 2 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
HZNP's average broker recommendation rating improved by 0.31 over the prior 13 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- HZNP has a higher average analyst price target than 1909.78% of all US stocks.
- HZNP has a higher number of analysts covering the stock than 2009.62% of Pharmaceutical Products stocks.
- In terms of how HORIZON THERAPEUTICS PUBLIC LTD CO fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 640.09% of that group.
- To contextualize these metrics, consider that out of stocks in the large market cap category, HORIZON THERAPEUTICS PUBLIC LTD CO's variance in analysts' estimates is lower than -1116.98% of them.
In the Pharmaceutical Products industry, JAZZ, BMRN, and VRTX are the three stocks most similar to HORIZON THERAPEUTICS PUBLIC LTD CO regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding HZNP using the data that counts. Try POWR Ratings for free.